34th week of 2016 patent applcation highlights part 9 |
Patent application number | Title | Published |
20160243156 | Bi-Functional Co-Polymer Use for Ophthalmic and Other Topical and Local Applications | 2016-08-25 |
20160243157 | POLYMERIC TREATMENT COMPOSITIONS | 2016-08-25 |
20160243158 | METHOD, COMPOSITION AND PACKAGE FOR BOWEL CLEANSING | 2016-08-25 |
20160243159 | WOUND TREATMENT COMPOSITION | 2016-08-25 |
20160243160 | PHOSPHATE BINDER FORMULATION FOR SIMPLE DOSING | 2016-08-25 |
20160243161 | DEVICE FOR GENERATING AND SUPPLYING GERMANIUM IONIC WATER | 2016-08-25 |
20160243162 | ANTI-INFLAMMATORY COMPOSITION FOR AIDING AND PROMOTING THE HEALING OF CHRONIC ULCERATIVE LESIONS | 2016-08-25 |
20160243163 | BIOCAMPATIBLE POLYMER COATED SILVER PRUSSIAN BLUE NANOPARTICLES (SPB-NPS: Ag3 [Fe (CN) 6]) | 2016-08-25 |
20160243164 | ANTIMICROBIAL SILVER HYDROGEL COMPOSITION FOR THE TREATMENT OF BURNS AND WOUNDS | 2016-08-25 |
20160243165 | PROCESSING CELL THERAPY PRODUCTS | 2016-08-25 |
20160243166 | MULTIPOTENT STEM CELLS AND USES THEREOF | 2016-08-25 |
20160243167 | COMPOSITIONS AND METHODS FOR MESENCHYMAL/STROMAL STEM CELL REJUVENATION AND TISSUE REPAIR BY ENHANCED CO-EXPRESSION OF TELOMERASE AND MYOCARDIN | 2016-08-25 |
20160243168 | ADOPTIVE CELL TRANSFER METHODS | 2016-08-25 |
20160243169 | DUAL VECTOR FOR INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS | 2016-08-25 |
20160243170 | Compositions and Methods for Restoring or Rejuvenating Stem/Progenitor Cell Function | 2016-08-25 |
20160243171 | THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS | 2016-08-25 |
20160243172 | Compositions and Methods for Inhibition of Pathogenic Bacterial Growth | 2016-08-25 |
20160243173 | PROBIOTIC ENHANCEMENT OF STEROID AND IMMUNE SUPPRESSOR ACTIVITY IN MAMMALS WITH CHRONIC DISEASES | 2016-08-25 |
20160243174 | NOVEL BACTERIA ISOLATED FROM FRESH HONEY OR THE HONEY PRODUCING TRACT OF HONEY BEES | 2016-08-25 |
20160243175 | COMPOSITIONS AND METHODS COMPRISING A DEFINED MICROBIOME AND METHODS OF USE THEREOF | 2016-08-25 |
20160243176 | EXTRACTS FROM PLANTS OF THE MORINGACEAE FAMILY AND METHODS OF MAKING | 2016-08-25 |
20160243177 | Method For Conducing Concentrated Cannabis Oil To Be Stable, Emulsifiable And Flavorless For Use In Hot Beverages and Resulting Powderized Cannabis Oil | 2016-08-25 |
20160243178 | Cannabis Conversion Process | 2016-08-25 |
20160243180 | ANTICANCER COMPOSITION CONTAINING MIXED HERBAL MEDICINE EXTRACT AS ACTIVE INGREDIENT | 2016-08-25 |
20160243181 | COMPOSITION FOR PREVENTING OR TREATING STROKE OR NEURODEGENERATIVE DISEASE, COMPRISING EXTRACT COMPLEX OF PUERARIA LOBATA AND SCUTELLARIA BAICALENSIS AS ACTIVE INGREDIENT | 2016-08-25 |
20160243182 | USE OF CISSAMPELOS PAREIRA EXTRACTS FOR TREATING DENGUE | 2016-08-25 |
20160243183 | EXTRACTION OF B-VITAMINS FROM PLANT MATTER | 2016-08-25 |
20160243184 | METHODS FOR NATURAL RELUBRICATION FOR VAGINAL ATROPHY | 2016-08-25 |
20160243185 | Bioactive-rich concentrates and nutritive and therapeutic products containing same | 2016-08-25 |
20160243186 | OBTAINING A JUICE OF FRESH PLANTS BY THERMOMECHANICAL TREATMENT AND COSMETIC AND THERAPEUTIC USE THEREOF | 2016-08-25 |
20160243187 | METHODS OF TREATING ACUTE MYELOID LEUKEMIA WITH A FLT3 MUTATION | 2016-08-25 |
20160243188 | AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS | 2016-08-25 |
20160243189 | MUCOADHESIVE NANOPARTICLE COMPOSITION COMPRISING IMMUNOSUPPRESANT AND METHODS OF USE THEREOF | 2016-08-25 |
20160243190 | DOSES AND METHODS FOR ADMINISTERING TELAVANCIN | 2016-08-25 |
20160243191 | Compositions for the Treatment of Cancer, and Methods for Testing and Using the Same | 2016-08-25 |
20160243192 | ANTIBODY DEPENDENT EXOSOME THERAPY | 2016-08-25 |
20160243193 | METHODS AND COMPOSITIONS FOR THE REDUCTION OF NEUTROPHIL INFLUX AND THE TREATMENT OF BRONCHOPULMONARY DISPLASIA, RESPIRATORY DISTRESS SYNDROME, CHRONIC LUNG DISEASE, PULMONARY FIBROSIS, ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2016-08-25 |
20160243194 | PUMA PROTEIN EXPRESSION VECTOR AND USE THEREOF IN GENE THERAPY | 2016-08-25 |
20160243195 | COMPOSITIONS INCLUDING IL-18 AND IL-22 AND THEIR USE IN ANTI-VIRAL THERAPIES | 2016-08-25 |
20160243196 | Methods of Using Interleukin-10 for Treating Diseases and Disorders | 2016-08-25 |
20160243197 | USE OF GHRELIN OR FUNCTIONAL GHRELIN RECEPTOR AGONISTS TO PREVENT AND TREAT STRESS-SENSITIVE PSYCHIATRIC ILLNESS | 2016-08-25 |
20160243198 | Pharmaceutical Composition for Preventing or Treating Osteoporosis Which Comprises Neuropeptide Y as Active Ingredient | 2016-08-25 |
20160243199 | LIQUID INSULIN FORMULATIONS AND METHODS RELATING THERETO | 2016-08-25 |
20160243200 | MEDICAMENT FOR TREATING OLFACTION DISORDER | 2016-08-25 |
20160243201 | METHODS AND COMPOSITIONS FOR INCREASING HEPCIDIN EXPESSION USING MODIFIED IRON BINDING/RELEASING TRANSFERRIN | 2016-08-25 |
20160243202 | COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF METABOLIC STEATOSIS AND STEATOHEPATITIS | 2016-08-25 |
20160243203 | TREATMENT OF POMPE'S DISEASE | 2016-08-25 |
20160243204 | CANDIDATES AGAINST INFECTION | 2016-08-25 |
20160243205 | RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF | 2016-08-25 |
20160243206 | Factor IX Polypeptides and Methods of Use Thereof | 2016-08-25 |
20160243207 | AGENT FOR USE IN THE CASE OF FRUCTOSE INTOLERANCE | 2016-08-25 |
20160243208 | FUSION MOLECULE BASED ON NOVEL TAA VARIANT | 2016-08-25 |
20160243209 | TUMOR ANTIGEN BASED ON PRODUCTS OF THE TUMOR SUPPRESSOR GENE WT1 | 2016-08-25 |
20160243210 | METHODS AND COMPOSITIONS BASED ON SHIGA TOXIN TYPE 2 PROTEIN | 2016-08-25 |
20160243211 | VACCINE COMPRISING PROTEIN NMB0964 FROM NEISSERIA MENINGITIDIS | 2016-08-25 |
20160243212 | Attenuated Mannheimia haemolytica Strains | 2016-08-25 |
20160243213 | Recombinant Protein Bodies as Immunogen-Specific Adjuvants | 2016-08-25 |
20160243214 | SUBGENOMIC REPLICONS OF THE FLAVIVIRUS DENGUE | 2016-08-25 |
20160243215 | STABILIZED HUMAN IMMUNODEFICIENCY VIRUS (HIV) CLADE C ENVELOPE (ENV) TRIMER VACCINES AND METHODS OF USING SAME | 2016-08-25 |
20160243216 | CMV IMMUNO-STIMULATORY COMPOSITION | 2016-08-25 |
20160243217 | MIXED ALLERGEN COMPOSITIONS AND METHODS FOR USING THE SAME | 2016-08-25 |
20160243218 | INHIBITION OF NONSENSE MEDIATED DECAY PATHWAYS | 2016-08-25 |
20160243219 | VACCINE COMPRISING STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE CONJUGATES | 2016-08-25 |
20160243220 | COMPOSITIONS AND METHODS FOR REDUCING ANTIGEN-SPECIFIC IMMUNOGENICITY | 2016-08-25 |
20160243221 | COMPOSITIONS AND METHODS FOR TOLERIZING CELLULAR SYSTEMS | 2016-08-25 |
20160243222 | NOVEL COMPOSITIONS AND ADJUVANTS | 2016-08-25 |
20160243223 | METHODS FOR TREATING CANCERS COMPRISING K-RAS MUTATIONS | 2016-08-25 |
20160243224 | TWEAK ANTAGONISTS FOR TREATING LUPUS NEPHRITIS AND MUSCLE ATROPHY | 2016-08-25 |
20160243225 | METHODS AND COMPOSITIONS COMPRISING A COMBINATION OF A VEGF ANTAGONIST AND AN ANTI-CTLA-4 ANTIBODY | 2016-08-25 |
20160243226 | Combination Therapy With Anti-CD74 and Anti-CD20 Antibodies Provides Enhanced Toxicity to B-Cell Diseases | 2016-08-25 |
20160243227 | ANTI-ANGIOGENESIS THERAPY FOR THE TREATMENT OF BREAST CANCER | 2016-08-25 |
20160243228 | METHODS, COMPOSITIONS, AND KITS FOR TREATMENT OF CANCER | 2016-08-25 |
20160243229 | ADENOASSOCIATED VIRAL MEDIATED PERSISTANT ANTI-VEGF THERAPY FOR OVARIAN CANCER | 2016-08-25 |
20160243230 | TARGETING IMMUNOTHERAPY FOR AMYLOIDOSIS | 2016-08-25 |
20160243231 | Ablative Immunotherapy | 2016-08-25 |
20160243232 | PROSTATE CANCER TREATMENT | 2016-08-25 |
20160243233 | MANAGEMENT OF TRACTIONAL MEMBRANES | 2016-08-25 |
20160243234 | ULTRASOUND MEDIATED DELIVERY OF DRUGS | 2016-08-25 |
20160243235 | METHODS AND SYSTEMS FOR TREATING CELL PROLIFERATION DISORDERS USING PLASMONICS ENHANCED PHOTOSPECTRAL THERAPY (PEPST) AND EXCITON-PLASMON ENHANCED PHOTOTHERAPY (EPEP) | 2016-08-25 |
20160243236 | HCD FORMULATION FOR CANCER TREATMENT | 2016-08-25 |
20160243237 | EMULSIONS OF PERFLUOROCARBONS | 2016-08-25 |
20160243238 | Compositions for Dermatological Use | 2016-08-25 |
20160243239 | PHARMACEUTICAL GELS AND METHODS FOR DELIVERING THERAPEUTIC AGENTS TO A SITE BENEATH THE SKIN | 2016-08-25 |
20160243240 | PREPARATION IN THE FORM OF A POWDER CONTAINING AT LEAST ONE CAROTENOID, AT LEAST ONE MODIFIED STARCH, AND SUCROSE | 2016-08-25 |
20160243241 | INHALABLE MEDICAMENT | 2016-08-25 |
20160243242 | HFSH AQUEOUS FORMULATION | 2016-08-25 |
20160243243 | ANTIPARASITIC AND/OR ANTIFUNGAL COMPOSITION COMPRISING HYDROPHOBISED CHITOSAN | 2016-08-25 |
20160243244 | METHOD AND SYSTEM FOR ALLEVIATING JOINT PAIN | 2016-08-25 |
20160243245 | Methods and Compositions for Enhancing Intranasal Delivery of Therapeutic Agents | 2016-08-25 |
20160243246 | HYALURONIC ACID-NUCLEIC ACID CONJUGATE AND COMPOSITION FOR NUCLEIC ACID DELIVERY CONTAINING THE SAME | 2016-08-25 |
20160243247 | METHODS TO INDUCE TARGETED PROTEIN DEGRADATION THROUGH BIFUNCTIONAL MOLECULES | 2016-08-25 |
20160243248 | GLYCOTARGETING THERAPEUTICS | 2016-08-25 |
20160243249 | HCV PROTEASE INHIBITORS AND USES THEREOF | 2016-08-25 |
20160243250 | TREATING INFLAMMATION USING LLP2A-BISPHOSPHONATE CONJUGATES AND MESENCHYMAL STEM CELLS | 2016-08-25 |
20160243251 | ARTIFICIAL TRANSCRIPTION FACTORS COMPRISING A SLIDING DOMAIN AND USES THEREOF | 2016-08-25 |
20160243252 | COMPOUNDS CONTAINING A VASCULAR DISRUPTING AGENT | 2016-08-25 |
20160243253 | TOLEROGENIC SYNTHETIC NANOCARRIERS | 2016-08-25 |
20160243254 | Theranostic Nanoprobes for Overcoming Cancer Multidrug Resistance and Methods | 2016-08-25 |
20160243255 | COMPOSITIONS AND METHODS FOR THE MANUFACTURE OF LIPID NANOPARTICLES | 2016-08-25 |
20160243256 | NUCLEIC ACID-LIPOPOLYMER COMPOSITIONS | 2016-08-25 |